# Fine-needle Diathermy Combined With Subconjunctival Bevacizumab for Corneal Neovascularization

> **NCT07642960** · NA · RECRUITING · sponsor: **HoChiMinh City Eye Hospital** · enrollment: 51 (estimated)

## Conditions studied

- Corneal Neovascularisation

## Interventions

- **PROCEDURE:** Fine-needle diathermy
- **DRUG:** Bevacizumab

## Key facts

- **NCT ID:** NCT07642960
- **Lead sponsor:** HoChiMinh City Eye Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2028-04-01
- **Final completion:** 2028-04-01
- **Target enrollment:** 51 (ESTIMATED)
- **Last updated:** 2026-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07642960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07642960, "Fine-needle Diathermy Combined With Subconjunctival Bevacizumab for Corneal Neovascularization". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07642960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*